Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 162

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein

Open access
Tang, Aimin, Chen, Zhifeng, Cox, Kara S., Su, Hua-Poo, Callahan, Cheryl, Fridman, Arthur, Zhang, Lan, Patel, Sangita B., Cejas, Pedro J., Swoyer, Ryan, Touch, Sinoeun, Citron, Michael P., Govindarajan, Dhanasekaran, Luo, Bin, Eddins, Michael, Reid, John C., Soisson, Stephen M., Galli, Jennifer, Wang, Dai, Wen, Zhiyun, Heidecker, Gwendolyn J., Casimiro, Danilo R., DiStefano, Daniel J., Vora, Kalpit A. · 2019 · Nature Communications

Abstract

Respiratory syncytial virus (RSV) infection is the leading cause of hospitalization and infant mortality under six months of age worldwide; therefore, the prevention of RSV infection in all infants represents a significant unmet medical need. Here we report the isolation of a potent and broadly neutralizing RSV monoclonal antibody derived from a human memory B-cell. This antibody, RB1, is equipotent on RSV A and B subtypes, potently neutralizes a diverse panel of clinical isolates in vitro and demonstrates in vivo protection. It binds to a highly conserved epitope in antigenic site IV of the RSV fusion glycoprotein. RB1 is the parental antibody to MK-1654 which is currently in clinical development for the prevention of RSV infection in infants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-12137-1

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 162

Metadata

Authors
Tang, A., Chen, Z., Cox, K. S., Su, H.-P., Callahan, C., Fridman, A., Zhang, L., Patel, S. B., Cejas, P. J., Swoyer, R., Touch, S., Citron, M. P., Govindarajan, D., Luo, B., Eddins, M., Reid, J. C., Soisson, S. M., Galli, J., Wang, D., Wen, Z., Heidecker, G. J., Casimiro, D. R., DiStefano, D. J., & Vora, K. A.
Venue
Nature Communications
Published
2019-09-12
Volume
10
Issue
1
Pages
4153-4153
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2972594574
Cited by
162
References
5
FWCI
7.78
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein. https://app.cochat.ai/papers/10.1038/s41467-019-12137-1
The paper
Tang, A., Chen, Z., Cox, K. S., Su, H.-P., Callahan, C., Fridman, A., Zhang, L., Patel, S. B., Cejas, P. J., Swoyer, R., Touch, S., Citron, M. P., Govindarajan, D., Luo, B., Eddins, M., Reid, J. C., Soisson, S. M., Galli, J., Wang, D., . . . Vora, K. A. (2019). A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein. Nature Communications. https://doi.org/10.1038/s41467-019-12137-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.